Anticancer agent 57
Modify Date: 2025-09-21 21:30:49
Anticancer agent 57 structure
|
Common Name | Anticancer agent 57 | ||
|---|---|---|---|---|
| CAS Number | 2408017-71-8 | Molecular Weight | 378.29 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H21Cl2NO2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Anticancer agent 57Anticancer agent 57 (compound 14) potently inhibits MDA-MB-231, MDA-MB-468, and MCF-7 cell lines, with IC50s of 6.43 ~ 8.00 μM. Anticancer agent 57 induces cell cycle arrest and significantly promotes apoptosis. Anticancer agent 57 inhibits tumor growth in nude mice xenografted with MADMB-231 cells. Anticancer agent 57 can be used for researching triple negative breast cancer (TNBC)[1]. |
| Name | Anticancer agent 57 |
|---|
| Description | Anticancer agent 57 (compound 14) potently inhibits MDA-MB-231, MDA-MB-468, and MCF-7 cell lines, with IC50s of 6.43 ~ 8.00 μM. Anticancer agent 57 induces cell cycle arrest and significantly promotes apoptosis. Anticancer agent 57 inhibits tumor growth in nude mice xenografted with MADMB-231 cells. Anticancer agent 57 can be used for researching triple negative breast cancer (TNBC)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 8.00 ± 0.07 μM in MDA-MB-231, 7.30 ± 0.04 μM in MDA-MB-468, 6.43 ± 0.18 μM in MCF-7[1] |
| References |
| Molecular Formula | C20H21Cl2NO2 |
|---|---|
| Molecular Weight | 378.29 |